Piper Sandler Maintains Neutral on Inari Medical, Raises Price Target to $80

Benzinga · 01/07 14:06
Piper Sandler analyst Adam Maeder maintains Inari Medical (NASDAQ:NARI) with a Neutral and raises the price target from $52 to $80.